- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 33/12 - Schistosomicides
Patent holdings for IPC class A61P 33/12
Total number of patents in this class: 87
10-year publication summary
|
6
|
6
|
1
|
5
|
6
|
2
|
3
|
3
|
2
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nihon Nohyaku Co., Ltd. | 326 |
3 |
| The University of Tokyo | 4386 |
3 |
| Merck Patent GmbH | 5742 |
2 |
| The Board of Trustees of the University of Illinois | 2755 |
2 |
| Aberystwyth University | 41 |
2 |
| Board of Regents of the University of Nebraska | 795 |
2 |
| Monash University | 732 |
2 |
| Rush University Medical Center | 302 |
2 |
| Swiss Tropical and Public Health Institute | 11 |
2 |
| Texas Tech University System | 660 |
2 |
| Tongli Biomedical Co., Ltd | 31 |
2 |
| University College Cardiff Consultants Limited | 249 |
2 |
| University of Georgia Research Foundation, Inc. | 1082 |
2 |
| University of L'Aquila | 5 |
2 |
| Zhejiang Hisun Pharmaceutical Co., Ltd. | 308 |
2 |
| Villya LLC | 15 |
2 |
| Jiangsu Insititute of Parasitic Diseases | 6 |
2 |
| Centre National de La Recherche Scientifique | 11092 |
1 |
| Bayer Intellectual Property GmbH | 2353 |
1 |
| Wisconsin Alumni Research Foundation | 3902 |
1 |
| Other owners | 48 |